MQS Management LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

MQS Management LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 837 shares of the medical equipment provider’s stock, valued at approximately $411,000.

Other institutional investors have also bought and sold shares of the company. Kingsview Wealth Management LLC increased its stake in Intuitive Surgical by 1.2% in the 1st quarter. Kingsview Wealth Management LLC now owns 4,144 shares of the medical equipment provider’s stock valued at $1,654,000 after buying an additional 51 shares during the last quarter. Brighton Jones LLC lifted its holdings in Intuitive Surgical by 5.2% during the first quarter. Brighton Jones LLC now owns 9,314 shares of the medical equipment provider’s stock worth $3,717,000 after acquiring an additional 457 shares during the period. Delos Wealth Advisors LLC boosted its position in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the last quarter. Wintrust Investments LLC increased its position in shares of Intuitive Surgical by 4.4% during the 1st quarter. Wintrust Investments LLC now owns 40,292 shares of the medical equipment provider’s stock valued at $16,080,000 after purchasing an additional 1,696 shares during the last quarter. Finally, M&G Plc bought a new stake in shares of Intuitive Surgical during the 1st quarter worth $1,318,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, General Counsel Gary Loeb sold 300 shares of the stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now owns 1,595 shares of the company’s stock, valued at approximately $757,625. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 91,178 shares of company stock worth $45,897,071. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ISRG shares. Raymond James raised their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup raised their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Royal Bank of Canada increased their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Stock Down 0.1 %

Shares of NASDAQ ISRG opened at $536.69 on Thursday. The firm has a market capitalization of $191.16 billion, a P/E ratio of 86.28, a P/E/G ratio of 5.28 and a beta of 1.39. The stock’s 50-day simple moving average is $495.85 and its two-hundred day simple moving average is $455.08. Intuitive Surgical, Inc. has a twelve month low of $287.98 and a twelve month high of $542.59.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.